Open Label Treatment of Severe Tactile Defensiveness With Intrathecal Baclofen

NCT01352611 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No subjects enrolled.

Conditions

Autism Spectrum Disorder

Interventions

DRUG: baclofen, intrathecal

Sponsor

University of Missouri-Columbia